Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorSequenom, Inc.
About this trial
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
Eligibility criteria
Qualifiers
pregnant between 10 and 22 weeks gestation
18 years of age or older
provides signed and dated informed consent
subject is at increased risk for fetal aneuploidy
Disqualifiers
Fetal demise at time of specimen sampling
Previous sample donation under this protocol
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov